November 2016

Editor's Page
Practical Considerations for Pathways
Winston Wong, PharmD, Editor-in-Chief

J Clin Pathways. 2016;2(9):7.

Columns

Pharma Insights
Creating Room to Show Value of New Products When Good Enough Treatments Exist
Dan Renick, RPh; Larry Blandford, PharmD—Column Editor

Journal of Clinical Pathways. 2016;2(9):33.

Commentary
Defining Target Populations for Clinical Pathways
David Hughes, BSN

J Clin Pathways. 2016;2(9):39-40.

Departments

Interview
ACS CAN Addresses Controversy Surrounding Opioids
Mark Fleury, PhD, MS

J Clin Pathways. 2016;2(9):27-30.

Research in Review
Feedback System Improves Physician Adherence to Oncology Clinical Pathways
JCP Editors

J Clin Pathways. 2016;2(9):16-21.

Research in Review
Review Examines Prognostic Value of Tumor-Infiltrating Lymphocytes in Early Breast Cancer
JCP Editors

J Clin Pathways. 2016;2(9):16-21.

Research in Review
Pediatric Stroke Pathway Improves Time to Definitive Diagnosis
JCP Editors

J Clin Pathways. 2016;2(9):16-21.

Research in Review
Significant Cost Savings From Enhanced Recovery Pathway for Colorectal Surgery
JCP Editors

J Clin Pathways. 2016;2(9):16-21.

Research in Review
Study Examines Cost-Effectiveness of Treatment Sequencing for HER2-Positive Breast Cancer
JCP Editors

J Clin Pathways. 2016;2(9):16-21.

Interview
Making Decisions About New Cancer Treatments With Limited Evidence
Jim C Hu, MD, MPH

J Clin Pathways. 2016;2(9):23-25.

Features

Review
Lessons From Change Management Theory for the Implementation of Clinical Pathways
Tobias Romeyke, PhD; Elisabeth Nöhammer, DHSc; Harald Stummer, PhD

J Clin Pathways. 2016;2(9):43-47. Received September 1, 2016; accepted October 25, 2016

Back to Top